In HCC, all-trans retinoic acid (ATRA) enhances TFPI2 via retinoic acid receptor alpha (RARα), modulated by MAF bZIP transcription factor B (MAFB, activator) and MAFF (repressor), influencing tumor invasion [111,112]. The gene discussed is MAF; the disease is hepatocellular carcinoma.